Načítá se...
Clinical Implementation of Germline Cancer Pharmacogenetic Variants during the Next-Generation Sequencing Era
Over 100 FDA-approved medications include pharmacogenetic biomarkers in the drug label, many with cancer indications referencing germline DNA variations. With the advent of next-generation sequencing (NGS) and its rapidly increasing uptake into cancer research and clinical practice, an enormous amou...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4128332/ https://ncbi.nlm.nih.gov/pubmed/24136381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2013.214 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|